A review on the role of HAND2-AS1 in cancer

Clin Exp Med. 2023 Nov;23(7):3179-3188. doi: 10.1007/s10238-023-01092-3. Epub 2023 May 19.

Abstract

HAND2 antisense RNA 1 (HAND2-AS1) is a newly recognized lncRNA encoded by a gene on 4q34.1. This lncRNA has 10 exons and is predicted to have a positive effect on expression of certain genes. HAND2-AS1 is mainly considered as a tumor suppressive lncRNA in different tissues. Moreover, HAND2-AS1 has been shown to regulate expression of several targets with possible roles in the carcinogenesis through serving as a sponge for miRNAs. This lncRNA can also influence activity of BMP, TGF-β1, JAK/STAT and PI3K/Akt pathways. Down-regulation of HAND2-AS1 in tumor tissues has been associated with larger tumor size, higher tumor grade, higher chance of metastasis and poor clinical outcome. The present study aims at summarization of the impact of HAND2-AS1 in the carcinogenesis and its potential in cancer diagnosis or prediction of cancer prognosis.

Keywords: Biomarker; Cancer; HAND2-AS1; Metastasis; Tumor; lncRNA.

Publication types

  • Review

MeSH terms

  • Carcinogenesis / genetics
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Gene Expression Regulation, Neoplastic
  • Humans
  • MicroRNAs* / genetics
  • Phosphatidylinositol 3-Kinases / metabolism
  • RNA, Long Noncoding* / genetics

Substances

  • RNA, Long Noncoding
  • Phosphatidylinositol 3-Kinases
  • MicroRNAs